A REVIEW ON RISK OF MYOCARDIAL INFARCTION FOLLOWING COVID-19 INFECTION

Dr. Srinivasarao Varagani*, Dr. Arepogu Ramesh, Dr. C. Sravani, Alapati Sathya Sai Guptha, Dr. Fizia Mohammadi, Haleema Kauser and Shubamalya L. G.

ABSTRACT

The COVID-19 pandemic produced by SARS-CoV-2 has had a major influence on cardiovascular health worldwide. New research indicates that those who have been afflicted have a higher risk of myocardial infarction (MI). This review summarizes recent research to clarify the complex pathways of MI following COVID-19 infection. The direct impact of viral invasion on the heart, systemic inflammation that causes endothelial dysfunction and hypercoagulability, and the aggravation of conventional cardiovascular risk factors are some of the important subjects discussed. Critical evaluation is given to the diagnostic difficulties and developments in biomarkers (e.g., troponin, CRP) and imaging modalities (echocardiography, CT angiography) for evaluating MI in COVID-19 patients. The review's conclusions highlight the significance of customized diagnostic strategies and focused treatment approaches in reducing the progressive cardiovascular effects of COVID-19. It also discusses future avenues for study and the consequences for public health policy, highlighting the necessity of integrated healthcare methods to maximize cardiovascular care in the aftermath of the epidemic.

Keywords: COVID-19, SARS-CoV-2, myocardial infarction, cardiovascular complications, biomarkers, imaging modalities, endothelial dysfunction, inflammation, hypercoagulability, diagnostic challenges, therapeutic strategies.